AbCellera Investor Presentation Deck

FULL YEAR 2021 BUSINESS UPDATE COPYRIGHT © ABCELLERA 8 ILLUSTRATIVE REVENUE PROFILE FOR ONE SUCCESSFUL PARTNERED PROGRAM. AbCellera participation in programs is strongly weighted towards downstream success. Years since program start Stage of program development research fees $3 million 1y 2y 3y discovery & preclinical 4y phase 1 5y clinical milestones $9 million 6y 7y phase 2 8y 9y phase 3 10y approval & commercial milestones $85 million 11y 12y commercial sales 13y || 14y Key assumptions, hypothetical: $1.7 billion peak sales, no price inflation, no patient population growth, 5% royalty, 6 years to peak sales, 5 years at peak sales, US approval only 15y 16y 17y royalties in aggregate of $765 million 18y 19y 20y 21y

View entire presentation